Ads
related to: lipitor pfizer astellas 5 000- Dosing & Administration
Efficacy, Safety, and Dosing
Information for HCPs
- Co-Pay Program
Resources
to Support Your Patients
- Safety
Safety Profile - Learn About
Adverse Patient Reactions
- Trial Results
See Clinical Data
and Trial
- Dosing & Administration
nexlizet.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Pfizer (NYS: PFE) used to sell Lipitor exclusively in the United States. And it was a huge component of the company's revenue and earnings. Honest. I swear. You certainly wouldn't know it from the ...
Pfizer introduced Lipitor in 1997, and the drug drove more than $130 billion in sales during its first 14 years on the market. The pharma distributors claimed Pfizer fraudulently sought to extend ...
Here's what's going on, what you need to know, and what you should do.The cold, hard factsThe Financial Times is reporting that pharmaceutical giant Pfizer (NYS: PFE) Pfizer Losing Lipitor Patent ...
From 1996 to 2012, under the trade name Lipitor, atorvastatin became the world's best-selling medication of all time, with more than $125 billion in sales over approximately 14.5 years. [ 117 ] and $13 billion a year at its peak, [ 118 ] Lipitor alone "provided up to a quarter of Pfizer Inc.'s annual revenue for years."
If an article from The Wall Street Journal about Pfizer's (NYS: PFE) plan to get an over-the-counter version of Lipitor approved is correct, big pharma is likely fighting a losing battle. On the ...
Torcetrapib (CP-529,414, Pfizer) was a drug being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.Its development was halted in 2006 when phase III studies showed excessive all-cause mortality in the treatment group receiving a combination of atorvastatin (Lipitor) and torcetrapib.